2025 Year in Review
2025 marked a turning point for BioInnovation Greece. What began as a grassroots initiative became a nationally recognized catalyst for biotech and health-tech entrepreneurship, connecting research, policy, founders, investors, and the global Greek diaspora.
Key milestones included expanding the core team and formal Board, launching BioSTART (Greece’s first proof-of-concept program) and designing its national fellowship model.
The BioInnovation Greece Forum 2025 at Technopolis hosted 580 participants and 167 speakers from 19 countries, alongside a landmark policy announcement on a future Ministry of Research and Development. The Forum concluded with the first BioSTART Competition.
2026 is underway with scale and execution as the focus.
Interested in partnering? Email us!
Mission
BioInnovation Greece (BiG) is a non-profit organization committed to advancing Greece's biotechnology and life sciences ecosystem by accelerating innovation, supporting entrepreneurship, and fostering strategic collaboration across academia, industry, government, and international partners.
Our mission is to catalyze the growth of a sustainable, globally connected biotech ecosystem that drives scientific discovery, economic development, and societal impact.
Our aim is to position Greece as a hub for biotech innovation and excellence through initiatives that support cutting-edge research, technology transfer, startup development, and cross-sector partnerships.
Key Objectives
-
Advance Research & Innovation: Support and promote cutting-edge research in biotechnology, including medical, pharmaceutical, agricultural, and environmental applications, with an emphasis on translational impact and global relevance.
-
Empower Startups & Entrepreneurs: Provide resources, mentorship, and strategic networking opportunities to early-stage biotech companies and innovators, helping them scale and succeed in Greece and beyond.
-
Enable Technology Transfer & Commercialization: Bridge the gap between research and real-world application by facilitating technology transfer, intellectual property development, and industry partnerships.
-
Foster Public-Private Collaboration: Create strong, cross-sectoral partnerships among academia, industry, government, and investors to align incentives, share resources, and drive systemic innovation.
-
Promote International Engagement: Build strategic alliances with global institutions, investors, and biotech leaders to bring international expertise, investment, and visibility to Greece’s biotech sector.
-
Build a Sustainable Biotech Ecosystem: Strengthen the infrastructure and talent pipeline necessary for long-term growth by cultivating a collaborative, inclusive, and resilient biotech community that contributes to health, economic growth, and global scientific leadership.
